Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALCR | P30988 | 4/20 | 0.51 |
| ▸ | OPRD1 | P41143 | 5/20 | 0.51 |
| ▸ | OXTR | P30559 | 1/20 | 0.51 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.49 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.49 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.49 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.49 |
| ▸ | NTSR1 | P30989 | 3/20 | 0.48 |
| ▸ | NTSR2 | O95665 | 1/20 | 0.48 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30445290 | 0.84 | OPRD1 (0.59) | CALCROPRD1OPRM1OPRK1NTSR1 | |
| SCHEMBL29420248 | 0.82 | NPY1R (0.62) | OPRD1NTSR1NTSR2SORT1 | |
| SCHEMBL14060698 | 0.82 | NPY1R (0.55) | CALCROPRD1OPRM1NTSR1NTSR2 | |
| SCHEMBL30423827 | 0.81 | NMUR2 (0.57) | OPRD1OPRM1 | |
| SCHEMBL15512342 | 0.81 | OPRD1 (0.52) | CALCROPRD1OXTRNTSR1 | |
| SCHEMBL29611985 | 0.81 | NPY1R (0.62) | OPRD1NTSR1NTSR2SORT1 | |
| SCHEMBL29612065 | 0.81 | NPY1R (0.62) | OPRD1NTSR1NTSR2SORT1 | |
| SCHEMBL29612082 | 0.81 | NPY1R (0.62) | OPRD1NTSR1NTSR2SORT1 | |
| SCHEMBL20707335 | 0.81 | NPY1R (0.62) | OPRD1NTSR1NTSR2SORT1 | |
| SCHEMBL29611692 | 0.81 | NPY1R (0.62) | OPRD1NTSR1NTSR2SORT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230173076-A1 | METABOLICALLY STABLE PEPTIDE ANALOGS | UNIV STRASBOURG (FR) | 2023-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230173076-A1 | METABOLICALLY STABLE PEPTIDE ANALOGS | GPR119, GLP1R, GIPR | CALCR 191/4885OPRD1 995/4885OXTR 990/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.